<div id="readability-page-1"><ul><li>Prologis Stock Surges: Why the Rally May Continue</li></ul><p>Prologis, Canopy Growth,  and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies whose earnings, revenue, or cash flow are expected to grow at an above‑average rate compared with the broader market, and are bought by investors mainly for capital appreciation rather than current income. These companies often reinvest profits into expansion, trade at higher valuation multiples (e.g., P/E ratios), and can be more volatile, so investors accept greater short‑term risk for the prospect of higher long‑term returns. These companies had the highest dollar trading volume of any Growth stocks within the last several days.</p><h2>Prologis (PLD)</h2><p>Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.</p><ul><li>3 Dividend Stocks to Hold Through Market Volatility This Fall</li></ul><p>Read Our Latest Research Report on PLD</p><h2>Canopy Growth (CGC)</h2><p>Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz &amp; Bickel segments.</p><ul><li>3 Cloud Build-Out Stocks Behind the AI Infrastructure Boom</li></ul><p>Read Our Latest Research Report on CGC</p><h2>Ascendis Pharma A/S (ASND)</h2><p>Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.</p><p>Read Our Latest Research Report on ASND</p><h2>Recommended Stories</h2><ul><li>MarketBeat's Top Five Stocks to Own in December 2025</li><li>How These 2 Stocks Won 2025's AI Race—And What's In Store for 2026</li><li>Intel Snaps Up AI Tech for Pennies on the Dollar</li><li>4 Quantum Stocks to Watch as the Next Computing Revolution Unfolds</li><li>Massive Breakout in Industrials: 3 Must-Watch Stocks Now</li><li>3 Tech Stocks Down Over 60%—Which One Is Worth Buying?</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Prologis Right Now?</h2><p>Before you consider Prologis, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prologis wasn't on the list.</p><p>While Prologis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ASND

<p>Prologis, Canopy Growth, and Ascendis Pharma A/S are highlighted as top growth stocks to watch by MarketBeat's stock screener tool. These companies are expected to have above-average growth in earnings, revenue, or cash flow. Prologis leads in logistics real estate, Canopy Growth focuses on cannabis products, and Ascendis Pharma develops therapies for unmet medical needs. Investors are advised to consider these stocks for potential long-term returns despite short-term risks.</p>

Top Growth Stocks To Add to Your Watchlist - December 17th